Modifying cell material may hold diabetes treatment potential

02/25/2013 | NewKerala.com (India)

Reprogramming the cell material chromatin helped trigger beta-cell gene expression in alpha cells among human and mouse cells, according to a study in the Journal of Clinical Investigation. "This would be a win-win situation for diabetics -- they would have more insulin-producing beta cells and there would be fewer glucagon-producing alpha cells," said lead author Klaus H. Kaestner.

View Full Article in:

NewKerala.com (India)

Published in Briefs:

SmartBrief Job Listings for Education

Job Title Company Location
Technical Assistance Associate (8156)
American Institutes for Research
Washington, DC
Senior Technical Assistance Consultant
American Institutes for Research
Washington, DC
Technical Assistance Consultant
American Institutes for Research
Washington, DC
Research Associate (7846)
American Institutes for Research
Washington, DC
Teacher
Saudi Aramco
Dhahran